Comment
doi: 10.1136/annrheumdis-2018-213044.
Epub 2018 Feb 2.
Additional comment to: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Scherlinger and Schaeverbeke
Affiliations
- PMID: 29420201
- DOI: 10.1136/annrheumdis-2018-213044
Item in Clipboard
Comment
Additional comment to: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Scherlinger and Schaeverbeke
Ann Rheum Dis.
2019 Apr.
No abstract available
Keywords: ankylosing sdpondylitis; anti-tnf; psoriatic arthritis; rheumatoid arthritis; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Additional response to the correspondence: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Cantini and Bennuci.Ann Rheum Dis. 2019 Apr;78(4):e26. doi: 10.1136/annrheumdis-2018-213342. Epub 2018 Mar 13. Ann Rheum Dis. 2019. PMID: 29535122 No abstract available.
Comment on
-
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases.Ann Rheum Dis. 2018 Feb;77(2):165-174. doi: 10.1136/annrheumdis-2017-211937. Epub 2017 Sep 2. Ann Rheum Dis. 2018. PMID: 28866648
-
Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?Ann Rheum Dis. 2019 Apr;78(4):e23. doi: 10.1136/annrheumdis-2017-212820. Epub 2017 Dec 29. Ann Rheum Dis. 2019. PMID: 29288210 No abstract available.
-
Response to: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Cantini and Benucci.Ann Rheum Dis. 2019 Apr;78(4):e24. doi: 10.1136/annrheumdis-2018-213021. Epub 2018 Jan 26. Ann Rheum Dis. 2019. PMID: 29374009 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
